Jazz Pharmaceuticals
JAZZ
#1938
Rank
A$15.10 B
Marketcap
A$248.58
Share price
1.67%
Change (1 day)
31.91%
Change (1 year)

EPS for Jazz Pharmaceuticals (JAZZ)

EPS in 2025 (TTM): A-$8.94

According to Jazz Pharmaceuticals's latest financial reports the company's current EPS (TTM) is A-$8.98. In 2024 the company made an earnings per share (EPS) of A$13.73 an increase over its 2023 EPS that were of A$9.87.

EPS history for Jazz Pharmaceuticals from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$8.94-165.12%
2024A$13.7339.08%
2023A$9.87-285.03%
2022A-$5.33-34.2%
2021A-$8.11-224.83%
2020A$6.49-53.25%
2019A$13.8923.59%
2018A$11.24-8.24%
2017A$12.2523.74%
2016A$9.9022.12%
2015A$8.11478.49%
2014A$1.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Endo International
ENDPQ
A-$1.61-82.05%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
AmerisourceBergen
ABC
A$12.49-239.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$11.09-223.49%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
A$0.95-110.57%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel